{"id":39605,"date":"2020-07-27T10:45:52","date_gmt":"2020-07-27T14:45:52","guid":{"rendered":"https:\/\/sciencebusiness.technewslit.com\/?p=39605"},"modified":"2020-07-27T10:45:52","modified_gmt":"2020-07-27T14:45:52","slug":"covid-19-vaccines-therapies-27-july-2020","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=39605","title":{"rendered":"Covid-19 Vaccines, Therapies \u2013 27 July 2020"},"content":{"rendered":"<figure id=\"attachment_39607\" aria-describedby=\"caption-attachment-39607\" style=\"width: 800px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2020\/07\/BioRenderCovid19Tracker-20200727.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-39607\" src=\"https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2020\/07\/BioRenderCovid19Tracker-20200727.jpg\" alt=\"Covid-19 vaccine and therapy tracker\" width=\"800\" height=\"453\" srcset=\"https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2020\/07\/BioRenderCovid19Tracker-20200727.jpg 800w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2020\/07\/BioRenderCovid19Tracker-20200727-300x170.jpg 300w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2020\/07\/BioRenderCovid19Tracker-20200727-768x435.jpg 768w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2020\/07\/BioRenderCovid19Tracker-20200727-150x85.jpg 150w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2020\/07\/BioRenderCovid19Tracker-20200727-400x227.jpg 400w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/><\/a><figcaption id=\"caption-attachment-39607\" class=\"wp-caption-text\">BioRender Covid-19 vaccine and therapy tracker. (BioRender.com)<\/figcaption><\/figure>\n<p>27 July 2020. A regular Monday feature each week on Science &amp; Enterprise is an update on Covid-19 therapies and vaccines in development. The report is provided by <a href=\"https:\/\/biorender.com\/\">BioRender<\/a>, in Toronto, Ontario, a company offering illustration and graphics tools for life sciences, biotechnology, and other disciplines.<\/p>\n<p>This week&#8217;s chart shows since last Monday more new activity for therapies than vaccines, with 15 new Covid-19 therapies joining the array of treatments in development. Of the 337 total therapies, 252 of these treatments are in clinical trials, a gain of 16 since last Monday. Also since last Monday, one more new candidate joined the Covid-19 vaccine collection raising the total to 156. Of that number, 34 vaccine candidates are in clinical trials, a gain of three since last week.<\/p>\n<p>In addition to the summary dashboard shown above, the BioRender Covid-19\u00a0<a href=\"https:\/\/biorender.com\/covid-vaccine-tracker\">vaccine and therapy page<\/a>\u00a0provides details of the vaccines and therapies, as well as an activity feed showing news updates on these drugs.<\/p>\n<p>A story in this morning&#8217;s <a href=\"https:\/\/nyti.ms\/30U14v0\">New York Times<\/a> reminds us that not all antibodies produced by Covid-19 vaccines, or the tests that detect them, are alike. The most potent neutralizing antibodies are those that block proteins on the SARS-CoV-2 coronavirus spike from infecting cells, while other antibodies bind to the virus without neutralizing it. Early-stage clinical trials look primarily for safety issues with vaccines, but also for the candidate&#8217;s ability to produce an immune response. As vaccines progress into later stage trials, we will watch for candidates&#8217; performance in producing these more potent antibodies.<\/p>\n<p>More from Science &amp; Enterprise:<\/p>\n<ul>\n<li><a href=\"https:\/\/sciencebusiness.technewslit.com\/?p=39590\">Synthetic Protein Designed to Boost Covid-19 Vaccines<\/a><\/li>\n<li><a href=\"https:\/\/sciencebusiness.technewslit.com\/?p=39558\">Oxford Covid-19 Vaccine Trial Invokes Immune Responses<\/a><\/li>\n<li><a href=\"https:\/\/sciencebusiness.technewslit.com\/?p=39554\">Covid-19 Vaccines, Therapies \u2013 20 July 2020<\/a><\/li>\n<li><a href=\"https:\/\/sciencebusiness.technewslit.com\/?p=39541\">Start-Up Developing Coronavirus Antibodies, Raises $50M<\/a><\/li>\n<li><a href=\"https:\/\/sciencebusiness.technewslit.com\/?p=39505\">Immune Responses Shown in Covid-19 Nasal Vaccine<\/a><\/li>\n<\/ul>\n<p style=\"text-align: center;\">*\u00a0\u00a0\u00a0\u00a0 *\u00a0\u00a0\u00a0\u00a0 *<\/p>\n","protected":false},"excerpt":{"rendered":"<p>This week&#8217;s chart shows since last Monday more new activity for therapies than vaccines, with 15 new Covid-19 therapies joining the array of treatments in development.<\/p>\n","protected":false},"author":1,"featured_media":39607,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[31,56,28,140,86,27,78],"class_list":["post-39605","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-products","tag-biomedical","tag-canada","tag-clinical-trials","tag-covid19","tag-engineering","tag-pharmaceuticals","tag-software"],"_links":{"self":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/39605","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=39605"}],"version-history":[{"count":2,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/39605\/revisions"}],"predecessor-version":[{"id":39608,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/39605\/revisions\/39608"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/media\/39607"}],"wp:attachment":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=39605"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=39605"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=39605"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}